Jove
Visualize
Contact Us

Related Experiment Videos

Chronic mucocutaneous candidiasis.

N Rosman

    Postgraduate Medical Journal
    |September 1, 1979
    PubMed
    Summary

    Chronic mucocutaneous candidiasis treatment remains challenging. Combining systemic antifungal therapy with immunotherapy shows promise but does not yet offer a permanent cure for this condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lack of human papillomavirus DNA in carcinoma cuniculatum.

    Acta dermato-venereologica·1994
    Same author

    Oropharyngeal and cutaneous candidosis in patients with decreased resistance to infections.

    Acta dermato-venereologica. Supplementum·1986
    Same author

    [Carcinoma cuniculatum. A rare warty tumor of the skin erroneously diagnosed].

    Ugeskrift for laeger·1983
    Same author

    Dermatophytes and dermatophytosis in Denmark 1979.

    Mykosen·1982
    Same author

    The social aspects of the treatment of spinal cord injured patients in Israel.

    Paraplegia·1982
    Same author

    Skin manifestations with vasculitis due to co-trimoxazole.

    Lancet (London, England)·1976
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Immunology
    • Mycology
    • Infectious Diseases

    Background:

    • Chronic mucocutaneous candidiasis (CMC) is a rare disorder characterized by persistent or recurrent infections of the skin, nails, and mucous membranes by Candida species.
    • The pathogenesis of CMC involves a complex interplay of host immune defects and fungal virulence factors.

    Purpose of the Study:

    • To survey the current understanding of chronic mucocutaneous candidiasis pathogenesis.
    • To review and evaluate existing and emerging treatment strategies for CMC.

    Main Methods:

    • Literature review of pathogenesis and treatment studies for chronic mucocutaneous candidiasis.
    • Analysis of treatment outcomes for topical antifungal, systemic antifungal, and immunotherapy approaches.
    • Evaluation of combination therapy and immunotherapy with transfer factor or live tissue.

    Main Results:

    • Topical antifungal treatments are generally insufficient for managing CMC.
    • Systemic antifungal treatments can be effective but are often followed by rapid relapses.
    • Specific immunotherapy, using transfer factor or live tissue, offers an alternative approach.
    • Combination therapy of systemic antifungals and immunotherapy appears most promising.

    Conclusions:

    • No definitive cure for chronic mucocutaneous candidiasis has been established.
    • Combined systemic antifungal therapy and immunotherapy represent the most promising therapeutic strategy currently available.
    • Further research is needed to develop more effective and potentially curative treatments for CMC.

    Related Experiment Videos